Literature DB >> 33704733

Detection of Uveal Melanoma by Multiplex Immunoassays of Serum Biomarkers.

Jin Song1, Zhen Zhang2, Daniel W Chan2.   

Abstract

Multiplex immunoassays simultaneously measure multiple analytes in a single sample providing quantitative data via parallel analyses, which is especially suitable for serum biomarker verification and validation. Multiplex immunoassays demonstrate several advantages over traditional enzyme-linked immunosorbent assays such as increasing productivity, conserving critical reagents and samples, and delivering results quickly. Here we describe the detection of uveal melanoma by magnetic bead-based multiplex immunoassays of serum biomarkers. The biomarker panels evaluated by multiplex immunoassays with high analytical performance demonstrated potential complementary values in detection of uveal melanoma.

Entities:  

Keywords:  Biomarker; Immunoassay; Multiplex; Serum; Uveal melanoma

Mesh:

Substances:

Year:  2021        PMID: 33704733     DOI: 10.1007/978-1-0716-1205-7_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2).

Authors:  Karen Hendler; Jacob Pe'er; Igor Kaiserman; Ronen Baruch; Inna Kalickman; Vivian Barak; Shahar Frenkel
Journal:  Anticancer Res       Date:  2011-01       Impact factor: 2.480

Review 2.  A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.

Authors:  H S Mudhar; M A Parsons; K Sisley; P Rundle; A Singh; I G Rennie
Journal:  Histopathology       Date:  2004-07       Impact factor: 5.087

3.  VEGF as a biomarker for metastatic uveal melanoma in humans.

Authors:  Vivian Barak; Jacob Pe'er; Inna Kalickman; Shahar Frenkel
Journal:  Curr Eye Res       Date:  2011-02-01       Impact factor: 2.424

4.  Comparison of multiplex immunoassay platforms.

Authors:  Qin Fu; Jie Zhu; Jennifer E Van Eyk
Journal:  Clin Chem       Date:  2009-12-18       Impact factor: 8.327

Review 5.  Prognostic parameters in uveal melanoma: a review.

Authors:  C M Mooy; P T De Jong
Journal:  Surv Ophthalmol       Date:  1996 Nov-Dec       Impact factor: 6.048

Review 6.  Developments in the management of uveal melanoma.

Authors:  Bertil Damato
Journal:  Clin Exp Ophthalmol       Date:  2004-12       Impact factor: 4.207

7.  Long-term survival of uveal melanoma patients after surgery for liver metastases.

Authors:  S Frenkel; I Nir; K Hendler; M Lotem; A Eid; O Jurim; J Pe'er
Journal:  Br J Ophthalmol       Date:  2009-05-07       Impact factor: 4.638

8.  Serum markers to detect metastatic uveal melanoma.

Authors:  Vivian Barak; Shachar Frenkel; Inna Kalickman; Andrew J Maniotis; Robert Folberg; Jacob Pe'er
Journal:  Anticancer Res       Date:  2007 Jul-Aug       Impact factor: 2.480

Review 9.  Bio-Rad's Bio-Plex® suspension array system, xMAP technology overview.

Authors:  Brett Houser
Journal:  Arch Physiol Biochem       Date:  2012-08-02       Impact factor: 4.076

10.  Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Authors:  Joshua D Cohen; Lu Li; Yuxuan Wang; Christopher Thoburn; Bahman Afsari; Ludmila Danilova; Christopher Douville; Ammar A Javed; Fay Wong; Austin Mattox; Ralph H Hruban; Christopher L Wolfgang; Michael G Goggins; Marco Dal Molin; Tian-Li Wang; Richard Roden; Alison P Klein; Janine Ptak; Lisa Dobbyn; Joy Schaefer; Natalie Silliman; Maria Popoli; Joshua T Vogelstein; James D Browne; Robert E Schoen; Randall E Brand; Jeanne Tie; Peter Gibbs; Hui-Li Wong; Aaron S Mansfield; Jin Jen; Samir M Hanash; Massimo Falconi; Peter J Allen; Shibin Zhou; Chetan Bettegowda; Luis A Diaz; Cristian Tomasetti; Kenneth W Kinzler; Bert Vogelstein; Anne Marie Lennon; Nickolas Papadopoulos
Journal:  Science       Date:  2018-01-18       Impact factor: 47.728

View more
  2 in total

Review 1.  Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.

Authors:  Nuno Jorge Lamas; Arnaud Martel; Sacha Nahon-Estève; Samantha Goffinet; Adam Macocco; Corine Bertolotto; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-12-25       Impact factor: 6.639

2.  Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays.

Authors:  Jin Song; Lori J Sokoll; Daniel W Chan; Zhen Zhang
Journal:  Biomedicines       Date:  2021-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.